Skip to content

Bibloc Mandibular Advancement Oral Device and Its Effect on TMJ Health

Relation Between Bibloc Mandibular Advancement Oral Appliance Used In Treatment of Obstructive Sleep Apnea and Tempromandibular Joint Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06492096
Enrollment
66
Registered
2024-07-09
Start date
2022-06-15
Completion date
2024-05-30
Last updated
2024-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea of Adult

Brief summary

The goal of this clinical trial is to learn if Mandibular Advancement Device( MAD) works to treat Obstructive sleep apnea in adults. It will also learn about the effect of the device on the Tempromandibular Joint Health . The main questions it aims to answer are: Does MAD lower the number of apnoea and hypopnea participants suffer from during sleep? Would it cause any effect on TMJ health? Researchers will compare between a group of TMD patients with OSA to a non\_TMD group of patients also with sleep apnea and both groups will receive a Bibloc MADplacebo (a look-alike substance that contains no drug) to see if it affect the TMJ health. Participants will: Wear MAD during sleep (at least 6 hours) every day for 6 months Visit the clinic once after the first week for checkups and adjustment of MAD If needed and then after 3 months and 6 months. Polysomnography, MRI, and tmd screening was done before the appliance insertion and after 6 months of its insertion.

Interventions

DEVICEBibloc Mandibular Advancement device

Each patient received a CAD/CAM designed Bibloc Mandibular Advancement device

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

\- Patients having obstructive sleep apnea syndrome (OSAS) as determined by polysomnography with mild to moderate apnea/hypopnea index ranging from 5 to 30 events per hour of sleep. ( As 5-15 events per hour is considered mild condition, 16-30 is considered moderate).(1) 2- Adequate nasal air flow capacity as determined by qualified otolaryngologist.

Exclusion criteria

* patients having Central sleep apnea events as determined by the polysomnography. 2- patients having cardiovascular disease. 3- History of alcohol, narcotic or psychoactive medications. 4- Serious nasal passage obstructions or allergies. 5- Previous history of treatment with any type of obstructive sleep apnea oral appliances. 6- Obese patients with BMI more than 30. 7- Missing more than five teeth (excluding third molar). 8- Allergy to acrylic resin.

Design outcomes

Primary

MeasureTime frameDescription
Apnea/Hypopnea index6 monthsNumber of apnea and hypopnea per hour of sleep

Secondary

MeasureTime frameDescription
Condylar disc position6 monthsIt appears in MRI and measured before and after the appliance insertion
Joint space of TMJ6 monthsmeasurement of joint space was done for each patient on their MRI before and after the treatment

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026